https://www.selleckchem.com/products/lxh254.html
The effectiveness of two vectored ND vaccines (Innovax® ND and Vectormune® ND) was tested, in single and prime-boost vaccination programs, against challenge with velogenic NDV genotype VII, in eight chicken groups (G). G1 and G2 were control groups. G3-5 received Innovax® ND, while G6-8 received Vectormune® ND on the hatchery. Additionally, G4 and G7 received live La Sota two-weeks later, and G5 and G8 received inactivated vaccine one-week later. On the challenge day, G3 (Innovax® ND vaccine alone) had lower HI titer than G6 (Vectormune®
Like
Comment
Share
